1. Home
  2. NRC vs MASS Comparison

NRC vs MASS Comparison

Compare NRC & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

SELL

Current Price

$21.12

Market Cap

449.7M

Sector

Health Care

ML Signal

SELL

Logo 908 Devices Inc.

MASS

908 Devices Inc.

SELL

Current Price

$11.95

Market Cap

498.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NRC
MASS
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.7M
498.1M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
NRC
MASS
Price
$21.12
$11.95
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $13.38
AVG Volume (30 Days)
100.6K
★ 378.6K
Earning Date
10-27-2026
11-09-2026
Dividend Yield
★ 3.03%
N/A
EPS Growth
★ 4707.69
125.47
EPS
★ N/A
N/A
Revenue
★ $119,686,000.00
$56,197,000.00
Revenue This Year
$3.79
$22.97
Revenue Next Year
$8.35
$19.41
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.81
N/A
52 Week Low
$11.32
$5.03
52 Week High
$23.68
$13.35

Technical Indicators

Market Signals
Indicator
NRC
MASS
Relative Strength Index (RSI) 53.19 54.30
Support Level $19.65 $11.14
Resistance Level $22.18 $13.35
Average True Range (ATR) 0.73 0.57
MACD 0.07 -0.11
Stochastic Oscillator 65.44 28.53

Price Performance

Historical Comparison
NRC
MASS

About NRC National Research Corporation (Delaware)

NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: